Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 8,885 shares of the stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $6.32, for a total transaction of $56,153.20. Following the transaction, the director now directly owns 7,407,420 shares in the company, valued at […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CFO Michael Secora sold 25,000 shares of the stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $6.32, for a total value of $158,000.00. Following the sale, the chief financial officer now directly owns 925,686 shares of the company’s […]
This stock spiked more than 10% Tuesday.
Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) had its price target cut by Needham & Company LLC from $17.00 to $15.00 in a research report sent to investors on Thursday morning, Benzinga reports. They currently have a buy rating on the stock. Separately, KeyCorp upped their price objective on shares of Recursion Pharmaceuticals from $12.00 to […]
We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare.